Literature DB >> 7785983

In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent.

G M Eliopoulos1, C B Wennersten, G Cole, D Chu, D Pizzuti, R C Moellering.   

Abstract

This study evaluated the in vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent. The drug inhibited all tested members of the family Enterobacteriaceae at < or = 0.5 microgram/ml and all tested Pseudomonas aeruginosa, Burkholderia (Pseudomonas) cepacia, and Xanthomonas maltophilia strains at < or = 2 micrograms/ml. All but two strains of gram-positive bacteria were inhibited by < or = 1 microgram of the new drug per ml, including isolates highly resistant to ciprofloxacin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785983      PMCID: PMC162641          DOI: 10.1128/AAC.39.4.850

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.

Authors:  E H Bingen; E Denamur; N Y Lambert-Zechovsky; J Elion
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

2.  High-level vancomycin-resistant enterococci causing hospital infections.

Authors:  A H Uttley; R C George; J Naidoo; N Woodford; A P Johnson; C H Collins; D Morrison; A J Gilfillan; L E Fitch; J Heptonstall
Journal:  Epidemiol Infect       Date:  1989-08       Impact factor: 2.451

3.  Emergence of vancomycin-resistant enterococci in New York City.

Authors:  T R Frieden; S S Munsiff; D E Low; B M Willey; G Williams; Y Faur; W Eisner; S Warren; B Kreiswirth
Journal:  Lancet       Date:  1993-07-10       Impact factor: 79.321

4.  In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.

Authors:  A S Ford; A L Baltch; R P Smith; W Ritz
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

  4 in total
  2 in total

1.  Activity of newer fluoroquinolones in vitro against gram-positive bacteria.

Authors:  G M Eliopoulos
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 2.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.